Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-042126
Filing Date
2025-05-12
Accepted
2025-05-12 17:27:16
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0239420-10q_inmed.htm   iXBRL 10-Q 834565
2 CERTIFICATION ea023942001ex31-1_inmed.htm EX-31.1 11689
3 CERTIFICATION ea023942001ex31-2_inmed.htm EX-31.2 11783
4 CERTIFICATION ea023942001ex32-1_inmed.htm EX-32.1 4227
5 CERTIFICATION ea023942001ex32-2_inmed.htm EX-32.2 4263
6 GRAPHIC image_001.jpg GRAPHIC 11732
  Complete submission text file 0001213900-25-042126.txt   5225159

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20250331.xsd EX-101.SCH 41985
8 XBRL CALCULATION FILE inm-20250331_cal.xml EX-101.CAL 44388
9 XBRL DEFINITION FILE inm-20250331_def.xml EX-101.DEF 208468
10 XBRL LABEL FILE inm-20250331_lab.xml EX-101.LAB 404297
11 XBRL PRESENTATION FILE inm-20250331_pre.xml EX-101.PRE 229440
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0239420-10q_inmed_htm.xml XML 594592
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 25936181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)